No abstract available
Keywords:
KMD-3213G; KMD-3293; LC–MS/MS; Silodosin; benign prostatic hyperplasia; bioanalytical method development; combination therapy; design of experiment; lower urinary tract symptoms; α1-adrenoceptor antagonist.
MeSH terms
-
Adrenergic alpha-1 Receptor Antagonists / blood*
-
Chromatography, Liquid / methods*
-
Humans
-
Indoles / blood*
-
Tandem Mass Spectrometry / methods*
Substances
-
Adrenergic alpha-1 Receptor Antagonists
-
Indoles
-
silodosin